Form 4 for CRBP Corbus Pharmaceuticals Holdings, Inc.
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-09 · accession 0001209191-22-017449 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-09 | 2022-03-09 | CRBP | Cohen Yuval | CEO, Dir | P - Purchase | $0.37 | +8,600 | 83.9K | +11% | +$3,182 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-09 | P | A | 8,600 | $0.37 | 83,930 | D | — | — |